Beneficial effects of atorvastatin on inflammatory parameters in patients with chronic kidney disease (CKD)

被引：0
|
作者：
Goicoechea, M.
Garcia de Vinuesa, S.
Puerta, M.
Kanter, J.
Gómez Campderá, F. J.
Cachofeiro, V.
Lahera, V.
Luño, J.
机构：
[1] Hosp Univ Gregorio Maranon, Madrid, Spain
[2] Univ Complutense, E-28040 Madrid, Spain
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S101 / S102
页数：2
相关论文
共 50 条
  • [41] Hospitalization in chronic kidney disease (CKD).
    Mix, C
    St Peter, WL
    Ebben, J
    Kausz, A
    Xue, J
    Collins, AJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 617A - 618A
  • [42] HIGHER STAGE OF CHRONIC KIDNEY DISEASE (CKD) IS A RISK FACTOR FOR PEPTIC ULCER DISEASE IN CKD PATIENTS
    Lee, Kyungnam
    Hwang, In Hye
    Lee, Soo Bong
    Lee, Dong Won
    Kim, Il Young
    Kwak, Ihm Soo
    Seong, Eun Young
    Shin, Min Ji
    Rhee, Harin
    Yang, Byeong Yun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 370 - 370
  • [43] The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan
    Garcia Trejo, Ehecatl Miguel Angel
    Arellano Buendia, Abraham Said
    Sanchez Reyes, Omegar
    Garcia Arroyo, Fernando Enrique
    Arguello Garcia, Raul
    Loredo Mendoza, Maria Lilia
    Tapia, Edilia
    Sanchez Lozada, Laura Gabriela
    Osorio Alonso, Horacio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09):
  • [44] Chronic Kidney Disease: Exercise Training has beneficial Effects
    Kraemer, Bernhard
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (06) : 248 - 248
  • [45] Vasoprotective effects of high density lipoprotein (HDL) are abolishes in patients with chronic kidney disease (CKD)
    Speer, T.
    Rohrer, L.
    Kraenkel, N.
    Shi, Y.
    Akhmedov, A.
    Von Eckardstein, A.
    Fliser, D.
    Luescher, T.
    Bahlmann, F.
    Landmesser, U.
    EUROPEAN HEART JOURNAL, 2011, 32 : 20 - 20
  • [46] Is diuretic use beneficial or harmful for patients with chronic kidney disease?
    Khan, Yusra Habib
    Sarriff, Azmi
    Mallhi, Tauqeer Hussain
    Adnan, Azreen Syazril
    Khan, Amer Hayat
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2017, 24 (04) : 253 - 254
  • [47] Effects on Serum Uric Acid by Difference of the Renal Protective Effects with Atorvastatin and Rosuvastatin in Chronic Kidney Disease Patients
    Kose, Eiji
    An, Taesong
    Kikkawa, Akihiko
    Matsumoto, Yoshiaki
    Hayashi, Hiroyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (02) : 226 - 231
  • [48] The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients
    Zumbrennen-Bullough, Kimberly
    Babitt, Jodie L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (02) : 263 - 273
  • [49] Regional arterial stiffness in diabetic patients with chronic kidney disease (CKD)
    Kimoto, E
    Shoji, T
    Hatsuda, S
    Shinohara, K
    Mori, K
    Fukumoto, S
    Koyama, H
    Emoto, M
    Ishimura, E
    Nishizawa, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 136 - 136
  • [50] Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review
    Homam Ibrahim
    Sunil V. Rao
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 519 - 527
12345